Kinetics of Bilirubin and Ammonia Elimination during Hemadsorption Therapy in Secondary Sclerosing Cholangitis Following ECMO Therapy and Severe COVID-19.

Tampe, Désirée; Korsten, Peter; Bremer, Sebastian C B; Winkler, Martin S; Tampe, Björn

Tampe, Désirée; Korsten, Peter; Bremer, Sebastian C B; Winkler, Martin S; Tampe, Björn.

Afiliação

Tampe D; Department of Nephrology and Rheumatology, University Medical Center Göttingen, 37075 Göttingen, Germany.
Korsten P; Department of Nephrology and Rheumatology, University Medical Center Göttingen, 37075 Göttingen, Germany.
Bremer SCB; Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center Göttingen, 37075 Göttingen, Germany.
Winkler MS; Department of Anesthesiology, Emergency and Intensive Care Medicine, University Medical Center Göttingen, 37075 Göttingen, Germany.
Tampe B; Department of Nephrology and Rheumatology, University Medical Center Göttingen, 37075 Göttingen, Germany.

Biomedicines ; 9(12)2021 Dec 05.

Article em En | MEDLINE | ID: mdl-34944657

Palavras-chave

COVID-19; CytoSorb; SSC-CIP; ammonia elimination; bilirubin elimination; extracorporeal membrane oxygenation; hemadsorption; intensive care medicine; secondary sclerosing cholangitis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Biomedicines Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Biomedicines Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha